文献速递主动脉外科

胸主动脉腔内修复术后早期与长期性别相关结局分析

An analysis of early and long-term gender-related outcomes after thoracic endovascular aortic repair.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

多中心回顾性观察队列研究纳入2005年1月至2023年4月TEVAR病例,按1:1粗化精确匹配151例男性与151例女性。女性与男性30天死亡率均为11.2%(P=1.0),血管入路并发症率4.0% vs 3.3%(P=1.0),总体生存(HR 0.8,95%CI 0.6-1.3,P=0.450)及免于TEVAR相关再干预均无统计学差异。

要点

  • 匹配后女性与男性30天死亡率均为11.2%,无统计学差异(P=1.0)。
  • 女性性别本身与TEVAR术后30天死亡及远期生存无显著关联。
  • 血管入路并发症与TEVAR相关再干预率在性别间无统计学差异。

核心结论

  • 女性性别本身与男性相比,未显示与更差的30天死亡率和远期生存相关。
  • 女性与男性具有相似的血管入路并发症率和TEVAR相关再干预率。

研究设计与样本

  • 多中心、回顾性、观察性队列研究,纳入2005年1月至2023年4月所有TEVAR病例。
  • 男性与女性按1:1粗化精确匹配,匹配后男性151例与女性151例。
  • 主要结局为30天死亡率和累积生存,次要结局为血管入路并发症和免于TEVAR相关再干预。

主要发现

  • 30天死亡率女性11.2% vs 男性11.2%(P=1.0),无统计学差异。
  • 二元logistic回归显示干预时长(P=0.001)和急诊TEVAR(P=0.001)与30天死亡率相关。
  • 血管入路并发症女性6例(4.0%)vs 男性5例(3.3%)(P=1.0),无统计学差异。
  • 中位随访46个月(四分位距7-84),男性中位50个月(11-95)vs 女性37.5个月(3.5-71.2)(P=0.153)。
  • Cox回归显示性别对总体生存无影响(HR 0.8;95%CI 0.6-1.3;P=0.450),估计生存log-rank χ2=0.6,P=0.442(95%CI 110.7-207.3)。

临床怎么用

  • 女性性别本身不应被视为TEVAR术后30天死亡或远期生存的独立危险因素。
  • 干预时长和急诊TEVAR与30天死亡率相关,临床决策中需关注。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate gender-related outcomes during endovascular treatment of thoracic and thoraco-abdominal aortic diseases (TEVAR). METHODS: Multicentre, retrospective, observational cohort study. All TEVARs between January 2005 and April 2023 were identified. Primary outcomes were 30-day mortality and cumulative survival. Secondary outcomes were vascular access complications, and freedom from TEVAR-related reintervention. Interventions performed in male patients were matched to females on the basis of a one-to-one coarsened exact matching. RESULTS: We identified 151 males who were matched with 151 females. Mortality at 30 days was not statistically different between females and males (11.2% vs 11.2%; P = 1.0). At binary logistic regression analysis, duration of intervention (P = 0.001) and emergency TEVAR (P = 0.001) were associated with mortality at 30 days. Gender did not impact the access vessel complication rate [n = 6 (4.0%) vs n = 5 (3.3%); P = 1.0]. The median follow-up was 46 (interquartile range, 7-84) months with no difference between males and females [median 50 (11-95) vs 37.5 (3.5-71.2); P = 0.153]. Estimated survival was not statistically different between females and males [log-rank χ2 = 0.6, P = 0.442; 95% confidence interval (CI) 110.7-207.3]. At Cox's regression analysis, gender did not impact overall survival (hazard ratio 0.8; 95% CI 0.6-1.3; P = 0.450). Estimated freedom from TEVAR-related reinterventions was not statistically different between females and males (log-rank χ2 = 0.4, P = 0.837; 95% CI 187.8-219.3). CONCLUSIONS: Female gender itself was not associated with worse 30-day mortality and late survival than males with similar access vessel complication as well as TEVAR-related reintervention rate.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Piffaretti G, Mauri F, Mozzetta G, et al. An analysis of early and long-term gender-related outcomes after thoracic endovascular aortic repair. Eur J Cardiothorac Surg. 2024. PMID: 39321279. doi:10.1093/ejcts/ezae343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。